Skip to content

Sensory Augmentation Methods in Stroke

Development of Sensory Augmentation Methods to Improve Post-stroke Gait Stability

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03988400
Acronym
SAM
Enrollment
44
Registered
2019-06-17
Start date
2022-04-04
Completion date
2023-04-26
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, gait

Brief summary

Many chronic stroke survivors have poor walking balance, contributing to an increased risk of falls and fear of falling. One factor contributing to these balance deficits is a reduced ability to place the feet appropriately when walking. This study investigates whether enhancing the sensory information available to chronic stroke survivors while they walk improves their foot placement accuracy and balance.

Detailed description

The objective of this project is to test a method of providing real-time augmentation of hip proprioceptive feedback during post-stroke walking. The sensory information available to participants will be augmented by providing vibration of the hip abductor musculature that is scaled to the near-real-time mechanical state of their body. The central hypothesis is that augmented proprioception will improve participants' perception of their body's motion, thus increasing the mechanics-dependent modulation of foot placement, an important gait stabilization strategy. This clinical trial will establish the safety, feasibility, and efficacy of a rehabilitation intervention centered on repeated exposure to sensory augmentation during gait. Specifically, participants in the experimental group will complete training sessions twice a week for four weeks in which they receive sensory augmentation during \ 30 minutes of treadmill walking. Participants in the activity-matched control group will perform the same task, except the hip vibration will be randomly delivered, not linked to the body's actual mechanical state. Changes in walking balance and foot placement accuracy will be quantified over the course of the intervention.

Interventions

Participants will complete 8 training sessions over 4 weeks, in which they walk on a treadmill at their self-selected speed. During training sessions, the magnitude of the vibration delivered over the hip abductor musculature will scale with the mechanical state of the pelvis at the start of each step. For example, if the step begins with the pelvis far mediolaterally from the stance foot, the swing leg hip abductors will receive strong vibration. If instead the step begins with the pelvis close mediolaterally to the stance foot, the stance hip abductors will receive strong vibration.

BEHAVIORALRandom Vibration

Participants will complete 8 training sessions over 4 weeks, in which they walk on a treadmill at their self-selected speed. During training sessions, the magnitude of the vibration applied to the hip abductors will vary randomly (following a normal distribution) on a step-by-step basis.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

Participants will be randomly assigned to either an Experimental (n=22) or Control (n=22) group. These groups will differ only in terms of how vibration is delivered to the hip musculature during training sessions. In the Experimental group, vibration magnitude will be controlled by the real-time mechanical state of the user's body. In the Control group, vibration magnitude will be randomly varied.

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Experience of a stroke 6 months prior to participation * Gait speed of at least 0.2 m/s * Ability to walk on a treadmill without a cane or walker * Provision of informed consent

Exclusion criteria

* Evidence of cerebellar damage * Resting blood pressure higher than 220/110 mm Hg * History of congestive heart failure, unstable cardiac arrhythmias, hypertrophic cardiomyopathy, severe aortic stenosis, angina or dyspnea at rest or during activities of daily living * Preexisting neurological disorders or dementia * Legal blindness or severe visual impairment * History of DVT or pulmonary embolism within 6 months * Uncontrolled diabetes with recent weight loss, diabetic coma, or frequent insulin reactions * Orthopedic injuries or conditions (e.g. joint replacements) in the lower extremities with the potential to alter the gait pattern

Design outcomes

Primary

MeasureTime frameDescription
Percentage of Participants With Related or Serious Adverse EventsCumulative over the course of the 4-week interventionThe investigators will monitor the safety of the intervention by quantifying the percentage of participants who experience an adverse event potentially related to the intervention (e.g. skin irritation; falls) or any serious adverse event (e.g. hospitalization; death). This information is gathered through participant self-report, or through communication with participant caregiver if necessary.
Number of Training Sessions AttendedCumulative over the course of the 4-week interventionThe investigators will assess participant adherence as the number of training sessions attended (out of a maximum possible number of 8).
Intervention Feasibility (Drop-out)4-weeksThe investigators will assess participant drop-out as the number of participants who do not attend the final Assessment Session.
Change in Mechanics-dependent Adjustment of Paretic Foot Placement4-weeksThe primary effectiveness measure will be the change in participants' gait stabilization strategy over the course of the 4-week intervention. This will be quantified as the partial correlation between paretic mediolateral foot placement and mediolateral pelvis displacement at the start of the step over a 2-minute period of walking. The investigators will calculate the change in this metric from the initial (Week 0) assessment session to the final (Week 4) assessment session.

Secondary

MeasureTime frameDescription
Intervention Feasibility (Walking Time)Cumulative over the course of the 4-week interventionThe investigators will quantify the total walking time across all training sessions (out of a maximum possible 312 minutes).
Change in Overground Self-selected Gait Speed4-weeksThe investigators will quantify the change in overground self-selected gait speed from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score will be subtracted from the final score.
Change in Fear of Falling4-weeksThe investigators will assess the change in fear of falling (identified using a yes/no question of do you have a fear of falling?) from the initial (Week 0) assessment session to the final (Week 4) assessment session.
Change in Functional Gait Assessment Score4-weeksThe investigators will quantify the change in Functional Gait Assessment score from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score will be subtracted from the final score. The minimum value is 0, the maximum value is 30, and higher scores indicate a better outcome.
Change in Activity-specific Balance Confidence Score4-weeksThe investigators will quantify the change in Activity-specific Balance Confidence score from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score will be subtracted from the final score. The minimum value is 0, the maximum value is 100, and higher scores indicate a better outcome.

Countries

United States

Participant flow

Recruitment details

Participants were recruited and enrolled into this study between April of 2022 and March of 2023. All participants were recruited from the RESTORE database at the Medical University of South Carolina.

Pre-assignment details

Participants completed an initial assessment session prior to their assignment to a study arm/group. No qualified participants were enrolled into the study, but then excluded from the study before group assignment.

Participants by arm

ArmCount
Sensory Augmentation
Participants will complete 8 training sessions over 4 weeks, in which they walk on a treadmill at their self-selected speed. During training sessions, the magnitude of the vibration delivered over the hip abductor musculature will scale with the mechanical state of the pelvis at the start of each step. For example, if the step begins with the pelvis far mediolaterally from the stance foot, the swing leg hip abductors will receive strong vibration. If instead the step begins with the pelvis close mediolaterally to the stance foot, the stance hip abductors will receive strong vibration. Sensory Augmentation: Participants will complete 8 training sessions over 4 weeks, in which they walk on a treadmill at their self-selected speed. During training sessions, the magnitude of the vibration delivered over the hip abductor musculature will scale with the mechanical state of the pelvis at the start of each step. For example, if the step begins with the pelvis far mediolaterally from the stance foot, the swing leg hip abductors will receive strong vibration. If instead the step begins with the pelvis close mediolaterally to the stance foot, the stance hip abductors will receive strong vibration.
22
Random Vibration
Participants will complete 8 training sessions over 4 weeks, in which they walk on a treadmill at their self-selected speed. During training sessions, the magnitude of the vibration applied to the hip abductors will vary randomly (following a normal distribution) on a step-by-step basis. Random Vibration: Participants will complete 8 training sessions over 4 weeks, in which they walk on a treadmill at their self-selected speed. During training sessions, the magnitude of the vibration applied to the hip abductors will vary randomly (following a normal distribution) on a step-by-step basis.
22
Total44

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyAdverse Event10
Overall StudyLost to Follow-up01
Overall StudyMacular degeneration, unrelated to study procedures.10

Baseline characteristics

CharacteristicTotalRandom VibrationSensory Augmentation
Activities-specific Balance Confidence scale score64.6 units on a scale
STANDARD_DEVIATION 19.6
64.2 units on a scale
STANDARD_DEVIATION 19.7
65.0 units on a scale
STANDARD_DEVIATION 20
Age, Continuous60 years
STANDARD_DEVIATION 13
57 years
STANDARD_DEVIATION 12
64 years
STANDARD_DEVIATION 12
Ethnicity (NIH/OMB)
Hispanic or Latino
1 Participants1 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
43 Participants21 Participants22 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Fear of Falling19 Participants11 Participants8 Participants
Functional Gait Assessment score15.25 units on a scale
STANDARD_DEVIATION 5.2
15.23 units on a scale
STANDARD_DEVIATION 4.66
15.27 units on a scale
STANDARD_DEVIATION 5.81
Mechanics-dependent adjustment of Non-paretic Foot Placement-.134 Unitless (correlation coefficient)
STANDARD_DEVIATION 0.247
-.075 Unitless (correlation coefficient)
STANDARD_DEVIATION 0.254
-.192 Unitless (correlation coefficient)
STANDARD_DEVIATION 0.231
Mechanics-dependent Adjustment of Paretic Foot Placement-.094 Unitless (correlation coefficient)
STANDARD_DEVIATION 0.247
-.043 Unitless (correlation coefficient)
STANDARD_DEVIATION 0.236
-.145 Unitless (correlation coefficient)
STANDARD_DEVIATION 0.253
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
18 Participants10 Participants8 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
26 Participants12 Participants14 Participants
Self-selected overground walking speed0.79 meter per second
STANDARD_DEVIATION 0.29
0.75 meter per second
STANDARD_DEVIATION 0.27
0.82 meter per second
STANDARD_DEVIATION 0.3
Sex: Female, Male
Female
12 Participants6 Participants6 Participants
Sex: Female, Male
Male
32 Participants16 Participants16 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 220 / 22
other
Total, other adverse events
0 / 220 / 22
serious
Total, serious adverse events
1 / 220 / 22

Outcome results

Primary

Change in Mechanics-dependent Adjustment of Paretic Foot Placement

The primary effectiveness measure will be the change in participants' gait stabilization strategy over the course of the 4-week intervention. This will be quantified as the partial correlation between paretic mediolateral foot placement and mediolateral pelvis displacement at the start of the step over a 2-minute period of walking. The investigators will calculate the change in this metric from the initial (Week 0) assessment session to the final (Week 4) assessment session.

Time frame: 4-weeks

Population: Analyses included participants who completed the final assessment session.

ArmMeasureValue (MEAN)
Sensory AugmentationChange in Mechanics-dependent Adjustment of Paretic Foot Placement0.078 Unitless (correlation coefficient)
Random VibrationChange in Mechanics-dependent Adjustment of Paretic Foot Placement0.054 Unitless (correlation coefficient)
p-value: 0.72t-test, 2 sided
Primary

Intervention Feasibility (Drop-out)

The investigators will assess participant drop-out as the number of participants who do not attend the final Assessment Session.

Time frame: 4-weeks

Population: Data from all participants enrolled in this study was analyzed.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sensory AugmentationIntervention Feasibility (Drop-out)2 Participants
Random VibrationIntervention Feasibility (Drop-out)1 Participants
p-value: 1Fisher Exact
Primary

Number of Training Sessions Attended

The investigators will assess participant adherence as the number of training sessions attended (out of a maximum possible number of 8).

Time frame: Cumulative over the course of the 4-week intervention

Population: Data was analyzed for all participants who completed the final assessment session.

ArmMeasureValue (MEDIAN)
Sensory AugmentationNumber of Training Sessions Attended7 Visits attended
Random VibrationNumber of Training Sessions Attended8 Visits attended
p-value: 0.017Wilcoxon (Mann-Whitney)
Primary

Percentage of Participants With Related or Serious Adverse Events

The investigators will monitor the safety of the intervention by quantifying the percentage of participants who experience an adverse event potentially related to the intervention (e.g. skin irritation; falls) or any serious adverse event (e.g. hospitalization; death). This information is gathered through participant self-report, or through communication with participant caregiver if necessary.

Time frame: Cumulative over the course of the 4-week intervention

Population: Analysis was performed on all participants who began the intervention.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Sensory AugmentationPercentage of Participants With Related or Serious Adverse Events1 Participants
Random VibrationPercentage of Participants With Related or Serious Adverse Events0 Participants
p-value: 1Fisher Exact
Secondary

Change in Activity-specific Balance Confidence Score

The investigators will quantify the change in Activity-specific Balance Confidence score from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score will be subtracted from the final score. The minimum value is 0, the maximum value is 100, and higher scores indicate a better outcome.

Time frame: 4-weeks

Population: Data was analyzed for participants who completed the final assessment session.

ArmMeasureValue (MEAN)
Sensory AugmentationChange in Activity-specific Balance Confidence Score1.0 score on a scale
Random VibrationChange in Activity-specific Balance Confidence Score2.1 score on a scale
p-value: 0.69t-test, 2 sided
Secondary

Change in Fear of Falling

The investigators will assess the change in fear of falling (identified using a yes/no question of do you have a fear of falling?) from the initial (Week 0) assessment session to the final (Week 4) assessment session.

Time frame: 4-weeks

Population: Analysis was performed for all participants who completed the final assessment session.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Sensory AugmentationChange in Fear of FallingFear of falling in initial assessment session8 Participants
Sensory AugmentationChange in Fear of FallingFear of falling in final assessment session8 Participants
Random VibrationChange in Fear of FallingFear of falling in initial assessment session10 Participants
Random VibrationChange in Fear of FallingFear of falling in final assessment session9 Participants
p-value: 0.68Wilcoxon (Mann-Whitney)
Secondary

Change in Functional Gait Assessment Score

The investigators will quantify the change in Functional Gait Assessment score from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score will be subtracted from the final score. The minimum value is 0, the maximum value is 30, and higher scores indicate a better outcome.

Time frame: 4-weeks

ArmMeasureValue (MEAN)
Sensory AugmentationChange in Functional Gait Assessment Score0.8 score on a scale
Random VibrationChange in Functional Gait Assessment Score1.7 score on a scale
p-value: 0.25t-test, 2 sided
Secondary

Change in Overground Self-selected Gait Speed

The investigators will quantify the change in overground self-selected gait speed from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score will be subtracted from the final score.

Time frame: 4-weeks

Population: Data was analyzed for participants who completed the final assessment session.

ArmMeasureValue (MEAN)
Sensory AugmentationChange in Overground Self-selected Gait Speed0.01 meters per second
Random VibrationChange in Overground Self-selected Gait Speed0.05 meters per second
p-value: 0.2t-test, 2 sided
Secondary

Intervention Feasibility (Walking Time)

The investigators will quantify the total walking time across all training sessions (out of a maximum possible 312 minutes).

Time frame: Cumulative over the course of the 4-week intervention

Population: Data was analyzed for all participants who completed the final assessment session.

ArmMeasureValue (MEDIAN)
Sensory AugmentationIntervention Feasibility (Walking Time)144 Minutes of walking
Random VibrationIntervention Feasibility (Walking Time)255 Minutes of walking
p-value: 0.001t-test, 2 sided
Post Hoc

Change in Mechanics-dependent Adjustment of Non-paretic Foot Placement

This not pre-planned effectiveness measure is the change in participant's gait stabilization over the course of the 4-week intervention for steps taken with the non-paretic leg. This was quantified as the partial correlation between non-paretic mediolateral foot placement and mediolateral pelvis displacement at the start of the step over a 2-minute period of walking. The change in this metric was calculated from the initial (Week 0) assessment session to the final (Week 4) assessment session. The initial score was subtracted from the final score.

Time frame: 4-weeks

Population: Analyses included participants who completed the final assessment session.

ArmMeasureValue (MEAN)
Sensory AugmentationChange in Mechanics-dependent Adjustment of Non-paretic Foot Placement0.073 Unitless (correlation coefficient)
Random VibrationChange in Mechanics-dependent Adjustment of Non-paretic Foot Placement0.037 Unitless (correlation coefficient)
p-value: 0.62t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026